Skip to main content
Have a personal or library account? Click to login
Oral N-acetylcysteine Trial for RYR1-related Myopathies Cover

Oral N-acetylcysteine Trial for RYR1-related Myopathies

Pediatric Neurology Briefs
Volume 36 (2022): Issue 0
By:   
Open Access
|Dec 2022
References

References

  1. Todd JJ Lawal TA Witherspoon JW Chrismer IC Razaqyar MS Punjabi M Randomized controlled trial of Nacetylcysteine therapy for RYR1-related myopathies Neurology 2020 Mar 94 13 e1434 44 https://doi.org/10.1212/WNL.0000000000008872 31941795
    Search in Google ScholarBack to article
  2. Lawal TA Todd JJ Meilleur KG Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches Neurotherapeutics 2018 Oct 15 4 885 899 do: https://doi.org/10.1007/s13311-018-00677-1
    Search in Google ScholarBack to article
DOI: https://doi.org/10.15844/pedneurbriefs-36-4 | Journal eISSN: 2166-6482
Journal RSS Feed
Language: English
Page range: 4 - 4
Submitted on: Dec 14, 2020
Accepted on: Dec 21, 2020
Published on: Dec 30, 2022
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
RYR1-RM,
N-acteylcysteine,
Clinical trial

© 2022 Vamshi Rao, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 36 (2022): Issue 0
Next article